Published
Keratin 17 (KRT17) is a key player in cancer drug resistance, affecting various cancers like bladder, breast, cervical, colorectal, esophageal, gastric, head and neck, lung, oral, pancreatic, skin, thyroid, and urothelial. This video explores KRT17's role in therapy resistance, its mechanisms, and emerging therapeutic strategies. Learn how KRT17 contributes to cancer progression, drug resistance, and potential treatment avenues.
- Categoria
- Oncology
Commenta per primo questo video.
Prossimo
-
07:29
Therapeutic Radiopharmaceuticals in Prostate Cancer: What the Urologist Needs to Know
-
05:21
Precision Oncology: Unlocking the Power of Robotic Surgery and Radiation Therapy
-
04:31
Emerging strategies for unresectable or advanced hepatocellular carcinoma
-
08:09
KRT17: Unlocking the Mystery of Cancer Therapy Resistance
-
08:59
Novel Therapies And New Emerging LDL Cholesterol Lowering Strategies - (Part 01/06) (PCS CWS-2025)
-
08:49
KRT17: A Key Driver of Cancer Therapy Resistance and Emerging Therapeutic Target
-
10:01
KRT17: The Hidden Protein Driving Cancer Therapy Resistance Explained
-
05:24
Unlocking Cancer Treatment: Radiation Therapy Revealed | Yashoda Hospitals Hyderabad
-
10:01
KRT17: Unlocking Cancer Therapy Resistance and Emerging Therapeutic Strategies
-
04:06
Mechanisms of resistance to checkpoint inhibitors in head & neck cancer
-
09:07
Cardiology for Beginners: Basics of Heart Sounds and Murmurs (with examples)
-
13:45
How to Become a Cardiologist | Cardiac Electrophysiologist
-
04:14
V 00592 Cardiology Fellowship Video Dr Vranian V5
-
05:17
Cardiology Fellowship at SIU Medicine
-
04:15
Cardiology Fellowship Program at Danbury Hospital
-
05:49
Practice Question: Cardiology #1, USMLE Step 1, COMLEX Level 1
-
04:07
Dr. Muhammed Raza on advice for Fellows interested in Interventional Cardiology
-
07:36
Congenital Heart Disease – Cardiology | Lecturio
-
05:18
Cardiology Fellowship at IU School of Medicine
-
04:36
What are different types of Cardiology Tests | SPS Hospitals
